Presentation is loading. Please wait.

Presentation is loading. Please wait.

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy  Ranjit.

Similar presentations


Presentation on theme: "Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy  Ranjit."— Presentation transcript:

1 Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy  Ranjit John, MD, Forum Kamdar, BS, Kenneth Liao, MD, Monica Colvin-Adams, MD, Andrew Boyle, MD, Lyle Joyce, MD  The Annals of Thoracic Surgery  Volume 86, Issue 4, Pages (October 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 External view of HeartMate II left ventricular assist device. (Illustration © Thoratec Corporation. Reproduced with permission.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Cross-sectional internal view of HeartMate II left ventricular assist device. (Illustration © Thoratec Corporation. Reproduced with permission.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Actuarial survival (Kaplan-Meier analysis) of patients undergoing HeartMate II placement as bridge-to-transplant therapy. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy  Ranjit."

Similar presentations


Ads by Google